Israeli and Swedish Firms Launch Prostate Cancer Imaging Kit in Nordic Markets

Jerusalem, 30 May, 2025 (TPS-IL) — Israeli radiopharmaceutical firm Isotopia Molecular Imaging and Swedish distributor Cardirad Nordic have launched Isoprotrace in Sweden and Denmark. The ready-to-use Gallium-68 Gozetotide kit enhances PET imaging for prostate cancer, aiding in both initial staging and suspected recurrence.

Cardirad will distribute the product across the two countries, expanding access to precision diagnostics in the region. Isoprotrace® is already approved in the Netherlands, UK, and Germany, with more EU rollouts expected.